NantWorks, Verizon to mobile enable cancer treatment protocols

By: Brian Dolan | Apr 18, 2012        

Tags: | | | | | | | | | | |  |

IPPLEX LookTel formerly SeeScanVerizon Communications has inked a deal with Dr. Patrick Soon-Shiong’s NantWorks to collaborate on a series of initiatives, beginning with an integrated information infrastructure that improves the treatment of cancer by equipping healthcare providers with the most up-to-date treatment protocols for specific cancer conditions right from their mobile devices. This first collaboration is called the Cancer Knowledge Action Network.

“The future of medicine is digital and mobile,” Soon-Shiong, founder and CEO of NantWorks, stated in a press release. “NantWorks and Verizon share a common vision for the transformation of the health care industry through ‘big data.’ As one of our first targets, we will explore ways to translate the massive amounts of data available on cancer treatment. Our goal is turn this data into actionable information at the point of care, enabling better care through mobile devices in hospitals, clinics and homes.”

Last year NantWorks announced plans to partner with Vodafone on developing wireless-enabled remote patient monitoring systems. Vodafone and Verizon are co-owners of Verizon Wireless. At the time, Soon-Shiong noted: “With Vodafone’s global mobile network, and its partner Verizon Wireless here in the United States, Vodafone is truly a global mobile powerhouse.”

Last month NantWorks announced that it had acquired remote monitoring technology company Boston Life Labs. NantWorks’ other acquisitions over the years include Vitality, maker of the medication adherence device GlowCap, as well as iVisit, which has developed the LookTel app for the visually impaired, among others. (The LookTel app officially launched earlier this year) The company is also working with Toumaz to bring that company’s peel-and-stick vital sign monitoring sensors to the US market.

The NantWorks announcement follows on Verizon’s recent move to combine its wired and wireless services and network assets to form an integrated health IT division. Verizon said that it has issued “tens of thousands” of credentials to healthcare professionals for its health information exchange offering. Verizon also recently inked an R&D deal with Duke University and a partnership with venture capital firm Health Evolution Partners.

For more details, read the press release below: Keep reading>>


Investors pump $100M into mobile health in Q1

By: Brian Dolan | Apr 17, 2012        


Brian Dolan, Editor, MobiHealthNewsThis week MobiHealthNews published its first quarterly report of 2012 — Mobile Health: State of the Industry Q1 2012. This edition actually marks the tenth “State of the Industry” report that MobiHealthNews has published since we began distilling our coverage into reports at the end of 2009. As always, it includes a roundup of the most important mobile health moves made by healthcare providers, health plans, mobile operators, pharma companies and others during the past three months.

Each of our State of the Industry reports also includes a roundup of the investments venture capitalists made into mobile health startups and companies as well as a list of the deals and partnerships we reports on during the quarter.

In total MobiHealthNews reported on more than $100 million worth of investments into mobile health companies during the quarter. Here were four deals that we believed to be notable, in no particular order: Keep reading>>

FDA clears Smartheart mobile ECG device

By: Brian Dolan | Apr 17, 2012        

Tags: | | | | |  |

Smartheart Mobile ECG SHL TelemedicineAs we reported in our Mobile Health: State of the Industry Q1 2012 report, the FDA cleared SHL Telemedicine’s Smartheart device, which is meant to be used by consumers to send their own 12 lead ECG data to a physician from the device. Smartheart transmits the ECG data to the user’s mobile phone via Bluetooth.

According to the company, “the Smartheart is a personal, hand-held battery powered, 12 lead ECG and rhythm strip device with Bluetooth connection. The Smartheart acquires ECG data via attached electrodes. The Smartheart transmits the data in real-time to a suitable Bluetooth communication device for forwarding it to a remote location and a certified medical professional capable of interpreting the results.”

Here’s how the FDA 510(k) summary describes the intended use cases for SHL’s device:

“The Smartheart device is intended to condition an electrocardiographic signal so that it can be transmitted digitally via Bluetooth technology and cellphone or communication device to a remote location. The Smartheart device is designed to be used by a patient to transmit a 12 lead ECG and rhythm strip in real-time to enable review at a physician’s office, hospital or other medical receiving center.”

SHL’s Smartheart device gained attention in the press after a demonstration at TechCrunch’s Disrupt event last year. At the time the company expected to sell the device for about $500 and an accompanying data analysis service that includes reports and medical advice would carry an additional subscription fee that the company said would cost “way” less than $20 each month.

While SHL’s device does include a 12 lead ECG, it is much more expensive than the more widely known (single lead) AliveCor iPhoneECG, which is not yet FDA cleared. The AliveCor device is expected to retail for about $100. As we reported in February, AliveCor expects to secure its CE Mark soon.

More on Smartheart’s FDA 510(k) clearance over at the FDA here. (PDF)
Catch up on more highlights from Q1 2012 by buying our Mobile Health: State of the Industry report here.

iPad platform promises 80 percent faster patient check-in

By: Neil Versel | Apr 17, 2012        

Tags: | | | | |  |

NIIT Healthcare MASH iPadA newly launched mobile platform for physician offices, hospitals, imaging centers and laboratories promises to speed up patient check-in time by 80 percent, reduce accounts receivable time and improve collaboration among providers.

NIIT Healthcare Technologies, the Florida-based healthcare division of Indian IT services company NIIT Technologies, has announced the general availability of a platform for the iPad called MASH – short for manage, analyze, sustain, harness – that ties together back-end health IT systems and delivers information to mobile devices.

According to the company, the MASH platform can support numerous applications for providers and patients alike. Patients can sign in on an iPad upon arrival (or they can pre-register online from home), pay their bills or carry a tablet with them to find their way through the facility with GPS-style, turn-by-turn directions. They also can make new appointments and opt in to receive automated reminders.

As soon as a patient signs in, the system notifies the front desk and any others who need to know the patient has arrived, and provides staff with any updated demographic and insurance information. MASH also supports secure messaging between clinicians and allows for targeted marketing to patients.

A second version, currently under development, will include biometric security features such as fingerprint and palm scanning. NIIT Healthcare Technologies says its programmers are trying to integrate technology that will read DNA from a palm scan for authentication.

“MASH 2 will also offer interactive tools that include a 3-D image of the human body, allowing patients to point to the areas where they are experiencing pain or injuries. This is especially useful for children or non-English speaking adults who will be able to show where they are in pain,” the company says in an e-mail.

To date, NIIT has installed MASH at Antelope Valley Hospital in Lancaster, Calif. – which the company says has the second-busiest emergency room in the state – and is implementing the technology at CentraState Medical Center in Freehold, N.J.

Sotera Wireless gets FDA nod for mobile vital sign monitor

By: Brian Dolan | Apr 17, 2012        

Tags: | | |  |

Sotera Wireless Visi MobileAs we noted in our recently published Mobile Health: State of the Industry Q1 2012 report, late last month the FDA granted Sotera Wireless 510(k) clearance for its wearable vital signs monitoring device, the ViSi Mobile Monitoring system. Sotera submitted the system to the FDA last August and received Class II 510(k) clearance on March 22nd of this year.

According to the company, “the ViSi Mobile Monitoring System is a lightweight, portable patient vital signs monitor featuring a high resolution, full color touch screen display, with visual and audible alarms and alerts. The ViSi Mobile Monitor is body-worn and designed to continuously measure ECG, heart rate, SpO2, pulse rate, respiration rate, and temperature. The ECG, SpO2, and Respiration waveforms are viewable on demand. NIBP can be measured as a onetime measurement, or it can be measured automatically at predefined intervals.”

Update: The version of the ViSi system that received FDA clearance does not include wireless transmission of data to computers or mobile devices for alerts, secondary viewing, or connectivity with EMR systems. It also does not include the company’s patented cuffless non-invasive blood pressure (cNIBP) sensor. Future versions of ViSi will include both, the company noted in a press release published Wednesday.

Here’s how the summary document from the FDA describes the system’s intended use:

“The ViSi Mobile Monitoring System is intended for use by clinicians and medically qualified personnel for single or multi-parameter vital signs monitoring of adult patients. It is indicated for ECG (3 or 5 leadwire), respiration rate (RESP), heart rate (H-R), non-invasive blood pressure (NIBP), non-invasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2 ), pulse rate (PR), and skin temperature (TEMP) in hospital-based facilities; including general medical-surgical floors, intermediate care floors, and emergency departments.”

While the device’s initial intended use is for inside healthcare facilities, the device will likely migrate to outpatient settings and eventually the home.

Sotera has already scooped up about $50 million in funding from various investors including Singapore-based global fund EDBI, Cerner Capital, Sanderling Ventures, Qualcomm Ventures, Intel Capital and the West Health Investment Fund. The company also already has a commercial partnership with Cerner and it has also collaborated with San Diego-based Palomar Pomerado Health to integrate its vital signs monitoring devices with Palomar’s Medical Information Anytime Anywhere (MIAA) platform, which aims to provide clinicians with access to patient medical records and vital sign information in real time or near-real time.

MobiHealthNews has been tracking Sotera for many years: Back in 2009 we noted that Sotera Wireless had changed its name from Triage Wireless as part of an agreement with Inverness Medical Innovations, which markets products under the Triage brand.

More news from the first quarter of 2012 in our Mobile Health State of the Industry Report here.
More on Sotera’s FDA clearance in this FDA 510(k) summary document. (PDF)
Update: Read more details in Sotera’s press release, below: Keep reading>>

Global mobile health market worth $8B by 2018

By: Brian Dolan | Apr 16, 2012        

Tags: | | | | | | |  |

Money TreeA recent report from Global Data pegged the global mHealth market as having a $500 million value in 2010 that will top $8 billion by 2018. The research firm argues that the rise of mobile health has been partially encouraged by the global financial crisis, which led to a focus on finding cost efficiencies in the system in addition to improved outcomes and quality of care.

Global Data also writes that mobile health offerings “have been shown to improve patient and physician convenience, enable remote monitoring, and improve care-coordination among medical professionals, patients and public health systems.” The firm also points to a notable increase in mHealth related product development and market consolidation.

Global Data’s $8 billion figure falls short when compared to other recently published mHealth market opportunity estimates: According to PricewaterhouseCoopers, the worldwide mHealth market will grow to a revenue opportunity worth $23 billion by 2017. PwC’s report was funded by the GSM Association and published during the first quarter of this year. According to the PwC report, the European market alone will have an almost $7 billion market opportunity by 2017 — a full year before Global Data’s $8 billion worldwide prediction.

More details in Global Data’s full press release below: Keep reading>>